Ep. 19 | Pharma Industry’s DNA Imparts Quality
To build our clients’ portfolios, we start at the company level with a rigorous fundamental, bottom-up research process.
To build our clients’ portfolios, we start at the company level with a rigorous fundamental, bottom-up research process.